Sign up USA
Proactive Investors - Run By Investors For Investors

Medtronic recalls diabetes infusion sets on concerns of over-delivery of insulin risk

"Our Medtronic Diabetes team will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support our customers throughout this process," said Francine Kaufman
Medtronic
Medtronic is the world’s largest manufacturer of pacemakers and defibrillators

Medtronic Inc (NYSE:MDT) has issued a voluntary recall of its diabetes infusion sets that are used with all models of its insulin pumps.

The recall comes after reports from patients that a discontinued component, the vent membrane, may be susceptible to being blocked by fluid during priming and fill-tubing.

The company said this can lead to over-delivery of insulin shortly after an infusion set change, which can lead to hypoglycemia.

READ: Medtronic skips lower as IT disruption hampers first quarter sales

Medtronic has recommended that customers use only infusion sets made with the new and enhanced membrane.

"Our Medtronic Diabetes team will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support our customers throughout this process," said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

View full MDT profile View Profile

Medtronic Timeline

Related Articles

the word antioxidant
August 15 2017
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction
picture of addict
Wed
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
ventripoint_device.png
June 21 2017
The device can give accurate and rapid volumetric information about all four chambers of the heart

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use